Sentences with phrase «in pharmacogenetics»

In addition, the resident will present at journal clubs, and may participate in the Pharmacogenetics Oversight Committee and other institutional meetings.

Amàlia Lafuente is a professor of pharmacology specializing in pharmacogenetics and vice chair of the Department of Pathological Anatomy, Pharmacology, and Microbiology in the School of Medicine at the University of Barcelona in Spain.

His major achievement is in the pharmacogenetic study of warfarin dose requirements, which resulted in the identification the SNP associated with warfarin dose.

Not exact matches

(Thanks to differences in physiology and pharmacogenetics, a single drug, for instance, can work very differently in two different healthy people, as it is.

«In addition to stem cells, the pharmacogenomics and pharmacogenetics arena is expected to be hot,» Burrill says.

In clinical sciences, pharmacogenetics, with a particular emphasis on Asian populations, would represent another niche area.

«Our new pharmacogenetic approach fills an important and unmet need in our ability to understand fly behaviors by allowing us for the first time to conveniently examine behaviors in only partially activated neurons to uncover more subtle roles for particular neurons and circuits in behaviors.»

In addition to warfarin, he is also in involves in other pharmacogenetic studies such as clopidogrel response, NSAID induced angioedema, drug induced Stevens - Johnson Syndrome and clinical studies using pharmacogenetic markerIn addition to warfarin, he is also in involves in other pharmacogenetic studies such as clopidogrel response, NSAID induced angioedema, drug induced Stevens - Johnson Syndrome and clinical studies using pharmacogenetic markerin involves in other pharmacogenetic studies such as clopidogrel response, NSAID induced angioedema, drug induced Stevens - Johnson Syndrome and clinical studies using pharmacogenetic markerin other pharmacogenetic studies such as clopidogrel response, NSAID induced angioedema, drug induced Stevens - Johnson Syndrome and clinical studies using pharmacogenetic markers.

He also actively participates in several major international consortium, such as International Warfarin Pharmacogenetic Consortium, International Clopidogrel Pharmacogenetic Consortium, Clinical Pharmacogenetics Implementation Consortium and worked with a group of experts to develop clinical use of HLA - B * 5801 and allopurinol.

«With the inauguration of the Institute for Personalized Medicine, we have reasserted our early leadership in the science of tailoring therapy to individuals, an approach that in some ways began at Hershey with the observations around pharmacogenetics by our founding chair of pharmacology, Elliot Vesell, more than 40 years ago,» said Daniel Notterman, vice dean for research and graduate studies.

The lovely violin plots at right show the mean GERP scores (a measure of conservation) for included versus excluded variants in the newborn screening (NBS), age - related macular degeneration (ARMD), and pharmacogenetics (PGx) genes examined.

Since her initial published findings in a 2001 issue of the journal Pharmacogenetics, Mealey discovered 12 other dog breeds, including Long - Haired Whippets and Silken Windhounds, are susceptible.

Abstract Type 1 ryanodine receptor (RyR1) is preferentially expressed in skeletal muscle, and mutations in the gene have been associated with malignant hyperthermia, a pharmacogenetic disease, and with several congenital myopathies, including central core disease, multiminicore disease, centronuclear myopathy, congenital fibre type disproportion.

Dr. van Schaik leads a research group on pharmacogenetics, in which the translation to implementation for patient diagnostics is the main topic.

He has been at the forefront of developing and applying new technologies for neural circuit manipulation, such as optogenetics and pharmacogenetics, to the study of emotional behaviors such as fear, anxiety and aggression, in both mice and fruit flies.

He identified and characterized significant biochemical and pharmacogenetic variation in human steroid 5a - reductase type II (encoded by the SRD5A2 gene) in 2000.

One of Dr. Innocentis exemplary achievements is the elucidation of the genetic basis of severe neutropenia in cancer patients treated with irinotecan, a poster child for pharmacogenetic.

He joined UNC in January 2011 after twelve years of research in cancer pharmacogenetics at the University of Chicago.

He has published over 75 articles on pharmacogenetics, and he participates in national and international advisory committees on this topic.

Today, the Golden Helix Foundation and the Section of Pharmacogenomics and Pharmacogenetics of International Union of Basic and Clinical Pharmacology (IUPHAR) have entered into a collaborative agreement to foster their cooperation and to advance basic and clinical research in pharmacogenomics, its clinical translation and educational and learning activities.

A pharmacogenetic «restriction - of - function» approach reveals evidence for anxiolytic - like actions mediated by α5 - containing GABAA receptors in mice.

Understanding individual variability in the effects of antipsychotic drugs - Pharmacogenetics to epigenetics

The Sections aims are, to promote the exchange of pharmacogenetic knowledge by organization of symposia and workshops in the field of pharmacogenetics and genomics, to evaluate the clinical impact of pharmacogenetics, to assist with the development and maintenance of drug - related pharmacogenetic databases and to create a population based biobank to conduct translational research in clinical pharmacogenomics.

3 - 4 pm: Stephen Miller (Poster presentation)- The I - PICC Study: Protocol for a point - of - care randomized controlled trial of statin pharmacogenetics in a learning healthcare system

He is a member of the Scientific Advisory Board of the Clinical Pharmacogenetic Implementation Consortium (CPIC) and a member of the CPIC informatics committee and has participated in guideline creation and review for that group.

Her primary interests are in treatment and pharmacogenetics of childhood leukemia and clinical implementation of pharmacogenetic testing.

Residents of nursing homes that performed pharmacogenetic testing had reductions in moderate to severe pain compared with those residing in nursing homes that did not do this type of personalized...

184/6: 15 Assessing the clinical impact of ethnicity - specific pharmacogenetic allele variation in over 100,000 patients with biobank - linked electronic medical records.

He has published over 175 articles in this field of pharmacogenetics.

The company was acquired in 2010 by Medco Health Solutions (with over 55 million Medco members) to provide pharmacogenetic testing services and clinical support focused on drug / gene interactions.

He participates in national and international advisory committees on pharmacogenetics, a.o. IFCC Task Force Pharmacogenetics (Chair), IATDMCT Pharmacogenetics Committee (chair), Dutch Task Force Pharmacogenetics (NVKC; chair), Dutch Committee on Molecular Biological Diagnostics (CMBD; chair), IUPHAR working group Pharmacogenetics (member), European Pharmacogenetics Research Network (Steering Committee), European Society for Personalized Medicine (EUSPM; treasurer), European Society for Pharmacogenetics and Theranostics (ESPT; Chair Scientific & Clinical Implementation Division), AACC Personalized Medicine Division (founding member) and the Pharmacogenetics Working Group of the European Medicipharmacogenetics, a.o. IFCC Task Force Pharmacogenetics (Chair), IATDMCT Pharmacogenetics Committee (chair), Dutch Task Force Pharmacogenetics (NVKC; chair), Dutch Committee on Molecular Biological Diagnostics (CMBD; chair), IUPHAR working group Pharmacogenetics (member), European Pharmacogenetics Research Network (Steering Committee), European Society for Personalized Medicine (EUSPM; treasurer), European Society for Pharmacogenetics and Theranostics (ESPT; Chair Scientific & Clinical Implementation Division), AACC Personalized Medicine Division (founding member) and the Pharmacogenetics Working Group of the European MediciPharmacogenetics (Chair), IATDMCT Pharmacogenetics Committee (chair), Dutch Task Force Pharmacogenetics (NVKC; chair), Dutch Committee on Molecular Biological Diagnostics (CMBD; chair), IUPHAR working group Pharmacogenetics (member), European Pharmacogenetics Research Network (Steering Committee), European Society for Personalized Medicine (EUSPM; treasurer), European Society for Pharmacogenetics and Theranostics (ESPT; Chair Scientific & Clinical Implementation Division), AACC Personalized Medicine Division (founding member) and the Pharmacogenetics Working Group of the European MediciPharmacogenetics Committee (chair), Dutch Task Force Pharmacogenetics (NVKC; chair), Dutch Committee on Molecular Biological Diagnostics (CMBD; chair), IUPHAR working group Pharmacogenetics (member), European Pharmacogenetics Research Network (Steering Committee), European Society for Personalized Medicine (EUSPM; treasurer), European Society for Pharmacogenetics and Theranostics (ESPT; Chair Scientific & Clinical Implementation Division), AACC Personalized Medicine Division (founding member) and the Pharmacogenetics Working Group of the European MediciPharmacogenetics (NVKC; chair), Dutch Committee on Molecular Biological Diagnostics (CMBD; chair), IUPHAR working group Pharmacogenetics (member), European Pharmacogenetics Research Network (Steering Committee), European Society for Personalized Medicine (EUSPM; treasurer), European Society for Pharmacogenetics and Theranostics (ESPT; Chair Scientific & Clinical Implementation Division), AACC Personalized Medicine Division (founding member) and the Pharmacogenetics Working Group of the European MediciPharmacogenetics (member), European Pharmacogenetics Research Network (Steering Committee), European Society for Personalized Medicine (EUSPM; treasurer), European Society for Pharmacogenetics and Theranostics (ESPT; Chair Scientific & Clinical Implementation Division), AACC Personalized Medicine Division (founding member) and the Pharmacogenetics Working Group of the European MediciPharmacogenetics Research Network (Steering Committee), European Society for Personalized Medicine (EUSPM; treasurer), European Society for Pharmacogenetics and Theranostics (ESPT; Chair Scientific & Clinical Implementation Division), AACC Personalized Medicine Division (founding member) and the Pharmacogenetics Working Group of the European MediciPharmacogenetics and Theranostics (ESPT; Chair Scientific & Clinical Implementation Division), AACC Personalized Medicine Division (founding member) and the Pharmacogenetics Working Group of the European MediciPharmacogenetics Working Group of the European Medicine Agency (EMA).

This paper provides a new method for selective inactivation the NMDA receptors in specific cell types using a novel pharmacogenetic methodology.

Similarly an accusation of deliberate murder by poisoning by a care home was revealed to have been likely to have naturally arisen as a result of a pharmacogenetic cause resulting in the victim being unable to excrete the prescribed tranquiliser in question.